Call us on: +27 21 808 9494
PharmaIntelligence is a management consulting company providing specialized services to healthcare and pharmaceutical companies and organisations.
Our services are bench-marked against International Pharmaceutical Industry standards and include the following areas:
The aim of GxP in the Pharmaceutical Industry is to ensure that products are manufactured that are safe and fit for use, meeting strict quality standards throughout the entire process of production.
The essence of GxP can be distilled down to the 5 Ps.
|Premises & Equipment|
The overall aim of the AMRH Programme is to support African countries to improve public health by increasing access to good quality, safe and effective medicines through harmonising medicines regulations, and expediting registration of essential medicines.
The South African Qualifications Authority (SAQA) accredited Pharmaceutical Sales Representation National Certificate (NQF-5) Course, overseen by the Chemical Industries Education and Training Authority (CHIETA)
The scope of health economics is encapsulated by dividing the discipline into eight topics:
Demonstrating and optimising value is key in Health Economics.
Value does however mean different things to different healthcare stakeholders (governments, doctors, patients etc) and new expansions beyond the traditional cost-effectiveness analysis is often proposed.
Below is an example of such a framework recently proposed by Garrison et al in 2017.
Each Healthcare Project is different and it is therefore critical to take a customised approach in the identification of:
By taking the customised approach the ‘true value picture’ will be created that will lead to the correct choice of healthcare technology.
At PharmaIntelligence we recognise the above requirement and assist clients to identify:
For healthcare decision makers, the adoption and implementation of innovations are complex and dynamic processes, requiring strong evidentiary support.
In general, decision-makers consider three key issues when making decisions:
In addition to money, Scientific Data is an important additional currency, used across all settings.
Data generated in various setting is processed into Scientific Evidence that is then used to guide decision making in the following general areas:
EBM is the process of systematically finding, appraising, and using contemporaneous research findings as the basis for clinical decisions.
Even though scientific evidence is the most reported type of evidence used during decision-making, other forms of evidence, including local data and clinical/professional experience are often used.
With this in mind, the need to understand the “complete value” underscores the need to consider multiple types of evidence as well as important contextual factors.
At PharmaIntelligence, we assist clients to